Abstract

to NZ$77,828 (95%UI $62,525, $94,718) for unresectable stage III/IV disease. The estimated total cost to New Zealand in 2021 for new patients with melanoma was NZ$51.2 m, and for KCs, was NZ$129.4 m, with a total combined cost of NZ$180.5 m. These up-to-date national healthcare costs of melanoma and KC in Australia and New Zealand accentuate the savings potential of successful prevention strategies for skin cancer.

Authors	Gordon, Louisa G; Leung, William; Johns, Richard; McNoe, Bronwen; Lindsay, Daniel; Merollini, Katharina M D; Elliott, Thomas M; Neale, Rachel E; Olsen, Catherine M; Pandeya, Nirmala; Whiteman, David C
Journal	International Journal Of Environmental Research And Public Health
Pages
Volume	19
Date	1/01/2022
Grant ID
Funding Body
URL	http://www.ncbi.nlm.nih.gov/pubmed/?term=10.3390/ijerph19063178